istock-508859346_walterbilotta-1

walterbilotta/ iStockphoto.com

10 November 2017Big Pharma

LSIPR 50 2017: Sean Dennehey—Steering the ship

2016 was a tumultuous year. Not only did the UK vote to leave the EU, but the UK Intellectual Property Office (IPO) lost its CEO and two experienced directors.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

LSPN: In-house ‘chess game’ is the same, but the rules have changed

Life sciences leaders recognised at LSPN Awards USA 2025

LSPN: Counsel grapple with AI’s impact on training and critical thinking

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB

Novartis settles with licensee of blood cancer therapy day before trial